Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norditropin in Turner Syndrome
NCT01518036Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 1987
- Primary completion
- Apr 2004
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Turner syndrome (TS), sponsored by Novo Nordisk. Started Sep 1987; status: completed.
02
Drugs
somatropin
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT01518036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518036.